Neuromodulation methods to alter glucose levels
US10070911B2 · kind B2 · utility
9Cited by
334References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2016 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Apr 4, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N7/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.